1-855-378-42281-855-378-4228
One of the out-patient treatment options for individuals in Petersburg who are battling with opioid abuse and addiction is called opioid maintenance therapy. Some facilities and doctors are authorized to give specific meds to opioid dependent clients, many that are opioid-based themselves and are habit forming. With low amounts however, the individual doesn't experience high feelings but also does not experience severe cravings and isn't in opioid withdrawal. Methadone is the first medication used for this reason, but there are alternative options to select from.
Methadone is an opiate and can be taken at an outpatient clinic licensed to dispense the med, that is taken on a daily basis in liquid or pill form. The cost of the med is about one hundred and fifty dolloars a month. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But unlike Methadone that can only be given in highly structured clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The price monthly of buprenorphine is about three hundred dollars /month for the generic version of the medication. There is also a version of buprenorphine containing the drug naloxone, that is a med which reverses the effects of opioids. An individual consuming this formulation, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced around $450 a month. Naltrexone is another med taken in opioid maintenance therapy, but unlike the other drugs mentioned it's an opiate blocker and isn't an opioid. A person has the choice to take this medication as a monthly shot, and that is called Vivitrol. As an opioid blocker, the drug prevents an individual from getting high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 a month.
For All Drug and Alcohol Rehabilitation Programs In Petersburg, Click Here.
